Company Metropolis Healthcare Limited
Equities
METROPOLIS
INE112L01020
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,903.40 INR | +1.00% |
|
-0.89% | -1.32% |
| Jan. 12 | Metropolis Healthcare Limited Launches Centre of Genomics to Scale Precision Diagnostics and Advance Research in India | CI |
| Jan. 04 | Metropolis Health standalone revenue growth at 15% YoY | RE |
Business description: Metropolis Healthcare Limited
Number of employees: 4,823
Sales by Activity: Metropolis Healthcare Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
Pathology Service | 9.98B | 12.28B | 11.48B | 12.08B | 13.31B |
Geographical breakdown of sales: Metropolis Healthcare Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
India | 9.59B | 11.81B | 10.92B | 11.06B | 12.22B |
outside India | 389M | 476M | 561M | 1.02B | 1.09B |
Executive Committee: Metropolis Healthcare Limited
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2023-01-01 | |
| Compliance Officer | - | 2024-02-02 | |
Kirti Chadha
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kannan Alangadan
COO | Chief Operating Officer | - | - |
| Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Metropolis Healthcare Limited
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 2024-05-21 | |
| Director/Board Member | 59 | 2017-12-31 | |
| Chairman | 79 | 2004-12-31 | |
| Director/Board Member | 62 | 2023-08-20 | |
Vivek Gambhir
BRD | Director/Board Member | 57 | 2017-12-31 |
Rehan A. Khan
BRD | Director/Board Member | - | 2025-05-12 |
Purvi Sheth
BRD | Director/Board Member | 53 | 2025-03-16 |
Hemant Sachdev
BRD | Director/Board Member | - | 2021-05-26 |
Company details: Metropolis Healthcare Limited
Medical & Diagnostic Laboratories
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.00% | -0.89% | +0.67% | +38.51% | 1.09B | |
| -3.78% | -1.31% | +46.03% | +464.30% | 31.99B | |
| -0.77% | +1.05% | -17.19% | -27.13% | 7.68B | |
| -2.74% | -9.22% | +18.59% | +252.13% | 5.49B | |
| -1.10% | -20.17% | +55.56% | +624.59% | 3.12B | |
| -0.95% | +0.24% | -1.84% | +30.08% | 2.57B | |
| -12.86% | +16.34% | +137.50% | -5.39% | 2.22B | |
| -9.37% | -3.15% | +26.21% | -60.96% | 2.17B | |
| -0.61% | +2.50% | - | - | 1.81B | |
| -0.31% | -2.81% | -9.99% | +8.30% | 1.65B | |
| Average | -3.15% | -4.58% | +28.39% | +147.16% | 5.98B | |
| Weighted average by Cap. | -3.30% | -2.78% | +33.75% | +309.90% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- METROPOLIS Stock
- Company Metropolis Healthcare Limited
Select your edition
All financial news and data tailored to specific country editions
